---
title: "AbbVie piles on $8 billion in debt for its Apogee deal -- should dividend investors worry?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295533701.md"
description: "The pharmaceutical company hopes that another big-time acquisition will pay off."
datetime: "2026-08-11T12:04:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295533701.md)
  - [en](https://longbridge.com/en/news/295533701.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295533701.md)
generator: "portal-rs"
---

# AbbVie piles on $8 billion in debt for its Apogee deal -- should dividend investors worry?

The pharmaceutical company hopes that another big-time acquisition will pay off.

### Related Stocks

- [APGE.US](https://longbridge.com/en/quote/APGE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md)
- [BUZZ-Street View: Strength in AbbVie's immunology pipeline to support revenue growth](https://longbridge.com/en/news/294686258.md)
- [AbbVie (NYSE:ABBV) Issues Q3 2026 Earnings Guidance](https://longbridge.com/en/news/294534219.md)
- [AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty](https://longbridge.com/en/news/292389611.md)
- [AbbVie beats earnings estimates, boosts 2026 outlook. What it means for the stock.](https://longbridge.com/en/news/284576830.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**